Pharmac

An outgoing leader at Pharmac says funding of the breast cancer drug Herceptin was the toughest decision he was involved in. Audio

Pharmac has decided to fund a new treatment for those with aggressive breast cancer, as an alternative to Herceptin. Audio

The Government's decision to side step Pharmac and fund the breast cancer drug Herceptin is being criticised. Audio

The drug-buying agency Pharmac has once again said no to funding the 12 month course of the breast cancer drug, Herceptin. Audio

Pharmac is to announce on today whether it will fund longer courses of Herceptin for women with early aggressive breast cancer Audio

The drug-buying agency has been completing it defence in a judicial review case brought by eight breast cancer patients. Audio

A legal challenge is brought by eight women against Pharmac over the breast cancer drug Herceptin. Audio

Karen Brown explores Pharmac's decision to fund a restricted nine-week course of the breast cancer drug, Herceptin Audio